DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yu, Su Jong | ko |
dc.contributor.author | Yoon, Jung-Hwan | ko |
dc.contributor.author | Won, Jae-Kyung | ko |
dc.contributor.author | Bin Lee, Yun | ko |
dc.contributor.author | Cho, Yuri | ko |
dc.contributor.author | Lee, Dong Hyeon | ko |
dc.contributor.author | Kim, Joon Suk | ko |
dc.contributor.author | Lee, Jeong-Hoon | ko |
dc.contributor.author | Kim, Yoon Jun | ko |
dc.contributor.author | Lee, Hyo-Suk | ko |
dc.contributor.author | Kim, Chung Yong | ko |
dc.date.accessioned | 2014-08-29T01:57:25Z | - |
dc.date.available | 2014-08-29T01:57:25Z | - |
dc.date.created | 2014-03-12 | - |
dc.date.created | 2014-03-12 | - |
dc.date.issued | 2013-10 | - |
dc.identifier.citation | HEPATOLOGY, v.58, pp.408A - 408A | - |
dc.identifier.issn | 0270-9139 | - |
dc.identifier.uri | http://hdl.handle.net/10203/188924 | - |
dc.language | English | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.title | Module-based analysis on Sorafenib-induced functional genomic changes of hepatocellular carcinoma reveals the optimal combination strategies of targeted drugs | - |
dc.type | Article | - |
dc.identifier.wosid | 000330252202018 | - |
dc.type.rims | ART | - |
dc.citation.volume | 58 | - |
dc.citation.beginningpage | 408A | - |
dc.citation.endingpage | 408A | - |
dc.citation.publicationname | HEPATOLOGY | - |
dc.contributor.nonIdAuthor | Yu, Su Jong | - |
dc.contributor.nonIdAuthor | Yoon, Jung-Hwan | - |
dc.contributor.nonIdAuthor | Bin Lee, Yun | - |
dc.contributor.nonIdAuthor | Cho, Yuri | - |
dc.contributor.nonIdAuthor | Lee, Dong Hyeon | - |
dc.contributor.nonIdAuthor | Kim, Joon Suk | - |
dc.contributor.nonIdAuthor | Lee, Jeong-Hoon | - |
dc.contributor.nonIdAuthor | Kim, Yoon Jun | - |
dc.contributor.nonIdAuthor | Lee, Hyo-Suk | - |
dc.contributor.nonIdAuthor | Kim, Chung Yong | - |
dc.type.journalArticle | Meeting Abstract | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.